Europe Anaphylaxis Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)

No. of Pages: 156    |    Report Code: TIPRE00023951    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Anaphylaxis Treatment Market

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Anaphylaxis Treatment Market – By Medication Type

1.3.2          Anaphylaxis Treatment Market – By Route of Administration

1.3.3          Anaphylaxis Treatment Market – By Allergy Type

1.3.4          Anaphylaxis Treatment Market – By Distribution Channel

1.3.5          Europe Anaphylaxis Treatment Market – By Country

2.           Europe Anaphylaxis Treatment Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Europe Anaphylaxis Treatment Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Anaphylaxis Treatment Market- Europe PEST Analysis

4.3          Expert Opinion

5.           Europe Anaphylaxis Treatment Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Rising Incidence of Anaphylaxis

5.1.2          Recent Approvals for Epinephrine

5.2          Market Restraints

5.2.1          Poor Access to Epinephrine Auto-Injectors in Low-Income Countries

5.3          Market Opportunities

5.3.1          Rise in Cases of Allergies Post Administration of COVID-19 Vaccines

5.4          Future Trends

5.4.1          Novel Drug Delivery Systems

5.5          Impact Analysis

6.           Anaphylaxis Treatment Market – Europe Analysis

6.1          Europe Anaphylaxis Treatment Market Revenue Forecasts and Analysis

7.           Europe Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Medication Type

7.1          Overview

7.2          Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)

7.3          Epinephrine

7.3.1          Overview

7.3.2          Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Antihistamines

7.4.1          Overview

7.4.2          Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Steroids

7.5.1          Overview

7.5.2          Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Beta-Agonist

7.6.1          Overview

7.6.2          Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.           Anaphylaxis Treatment Market Analysis – By Route of Administration

8.1          Overview

8.2          Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)

8.3          Oral

8.3.1          Overview

8.3.2          Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Parenteral

8.4.1          Overview

8.4.2          Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Others

8.5.1          Overview

8.5.2          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Anaphylaxis Treatment Market Analysis and Forecasts To 2028 – By Allergy Type

9.1          Overview

9.2          Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)

9.3          Food Allergy

9.3.1          Overview

9.3.2          Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Medications

9.4.1          Overview

9.4.2          Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Insect Stings

9.5.1          Overview

9.5.2          Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Anaphylaxis Treatment Market Analysis and Forecasts to 2028– By Distribution Channel

10.1        Overview

10.2        Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)

10.3        Retail Sales

10.3.1        Overview

10.3.2        Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

10.4        Hospital Pharmacies

10.4.1        Overview

10.4.2        Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

10.5        Others

10.5.1        Overview

10.5.2        Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)

11.        Anaphylaxis Treatment Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1        Europe: Anaphylaxis Treatment Market

11.1.1        Overview

11.1.2        Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

11.1.2.1          Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1           Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2           Germany: Anaphylaxis Treatment Market, by Medication Type 2019–2028 (USD Million)

11.1.2.1.3           Germany: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.1.2.1.4           Germany: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.1.2.1.5           Germany: anaphylaxis treatment Market, by Allergy Type 2019–2028 (USD Million)

11.1.2.1.6           Germany: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)

11.1.2.2          UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1           UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2           UK: Anaphylaxis Treatment Market, Medication Type, 2019–2028 (USD Million)

11.1.2.2.3           UK: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.1.2.2.4           UK: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.1.2.2.5           UK: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)

11.1.2.2.6           UK: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)

11.1.2.3          France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1           France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2           France: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.1.2.3.3           France: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.1.2.3.4           France: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.1.2.3.5           France: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)

11.1.2.3.6           France: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)

11.1.2.4          Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.4.1           Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.4.2           Italy: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.1.2.4.3           Italy: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.4.4           Italy: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.4.5           Italy: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.1.2.4.6           Italy: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.2.5          Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.5.1           Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.5.2           Spain: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.1.2.5.3           Spain: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.5.4           Spain: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.5.5           Spain: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.1.2.5.6           Spain: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.2.6          Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.6.1           Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.6.2           Rest of Europe: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.1.2.6.3           Rest of Europe: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.6.4           Rest of Europe: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.6.5           Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.1.2.6.6           Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

12.        Impact Of COVID-19 Pandemic on Europe Anaphylaxis Treatment Market

12.1        Europe: Impact Assessment of COVID-19 Pandemic

13.        Industry Landscape

13.1        Overview

13.2        Growth Strategies Done by the Companies in the Market, (%)

13.3        Organic Developments

13.3.1        Overview

13.4        Inorganic Developments

13.4.1        Overview

14.        COMPANY PROFILES

14.1        Abbott

14.1.1        Key Facts

14.1.2        Business Description

14.1.3        Products and Services

14.1.4        Financial Overview

14.1.5        SWOT Analysis

14.2        ALK-Abelló A/S

14.2.1        Key Facts

14.2.2        Business Description

14.2.3        Products and Services

14.2.4        Financial Overview

14.2.5        SWOT Analysis

14.2.6        Key Developments

14.3        Amneal Pharmaceuticals, Inc.

14.3.1        Key Facts

14.3.2        Business Description

14.3.3        Products and Services

14.3.4        Financial Overview

14.3.5        SWOT Analysis

14.3.6        Key Developments

14.4        BIOPROJET

14.4.1        Key Facts

14.4.2        Business Description

14.4.3        Products and Services

14.4.4        Financial Overview

14.4.5        SWOT Analysis

14.4.6        Key Developments

14.5        GlaxoSmithKline plc.

14.5.1        Key Facts

14.5.2        Business Description

14.5.3        Products and Services

14.5.4        Financial Overview

14.5.5        SWOT Analysis

14.5.6        Key Developments

14.6        Merck & Co., Inc.

14.6.1        Key Facts

14.6.2        Business Description

14.6.3        Products and Services

14.6.4        Financial Overview

14.6.5        SWOT Analysis

14.6.6        Key Developments

14.7        MYLAN N.V.

14.7.1        Key Facts

14.7.2        Business Description

14.7.3        Products and Services

14.7.4        Financial Overview

14.7.5        SWOT Analysis

14.7.6        Key Developments

14.8        Pfizer Inc.

14.8.1        Key Facts

14.8.2        Business Description

14.8.3        Products and Services

14.8.4        Financial Overview

14.8.5        SWOT Analysis

14.8.6        Key Developments

14.9        TEVA PHARMACEUTICAL INDUSTRIES LTD

14.9.1        Key Facts

14.9.2        Business Description

14.9.3        Products and Services

14.9.4        Financial Overview

14.9.5        SWOT Analysis

14.9.6        Key Developments

15.        Appendix

15.1        About the Insight Partners

15.2        Glossary of Terms

 


LIST OF TABLES

Table 1.              Germany: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              Germany: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 3.              Germany: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4.              Germany: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 5.              Germany: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

Table 6.              UK: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 7.              UK: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 8.              UK: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 9.              UK: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 10.            UK: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

Table 11.            France: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 12.            France: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 13.            France: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.            France: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 15.            France Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 16.            Italy: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 17.            Italy: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 18.            Italy: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 19.            Italy: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 20.            Italy: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 21.            Spain: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 22.            Spain: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 23.            Spain: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 24.            Spain: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 25.            Spain: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 26.            Rest of Europe: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 27.            Rest of Europe: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 28.            Rest of Europe: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 29.            Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 30.            Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 31.            Organic Developments Done by Companies

Table 32.            Inorganic Developments Done by Companies

Table 33.            Glossary of Terms, Anaphylaxis Treatment Market

 


LIST OF FIGURES

Figure 1.            Anaphylaxis Treatment Market Segmentation

Figure 2.            Europe Anaphylaxis Treatment Market Overview

Figure 3.            Epinephrine Segment Held Largest Share of Medication Type in Anaphylaxis Treatment Market

Figure 4.            UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Anaphylaxis Treatment Market - Europe PEST Analysis

Figure 6.            Anaphylaxis Treatment Market Impact Analysis of Driver and Restraints

Figure 7.            Europe Anaphylaxis Treatment Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)

Figure 9.            Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)

Figure 15.          Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.          Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)

Figure 19.          Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.          Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)

Figure 24.          Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 25.          Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 26.          Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)

Figure 27.          Europe: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)

Figure 28.          Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

Figure 29.          Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.          UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.          France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.          Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.          Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.          Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.          Impact of COVID-19 Pandemic in European Country Markets

Figure 36.          Growth Strategies Done by the Companies in the Market, (%)

 

 

The List of Companies - Europe Anaphylaxis Treatment Market

  1. Amneal Pharmaceuticals Inc.
  2. Mylan N.V.
  3. Abbott
  4. Pfizer Inc.
  5. Glaxosmithkline Plc.,
  6. Merck And Co., Inc.
  7. Teva Pharmaceutical Industries Ltd.        
  8. ALK-ABELLó   
  9. BIOPROJET